Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-09-28

FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Original Application (H2-Pharma, LLC)

View source ↗

Summary

The FDA approved a new drug product consisting of bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride (H2-Pharma, LLC) under an Original…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride (Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride)

Snippet

ORIG AP for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE (BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE)